Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Front-line”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03847844
What this trial is testing

UCMSCs as Front-line Approach of Treatment for Patients With aGVHD

Who this might be right for
Acute-graft-versus-host Disease
Cytopeutics Sdn. Bhd. 26
Not applicableEnded earlyNCT04698681
What this trial is testing

NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 20
Testing effectiveness (Phase 2)UnknownNCT05585281
What this trial is testing

Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Cancer
Yongpeng Wang 25
Testing effectiveness (Phase 2)Study completedNCT02561273
What this trial is testing

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveHepatosplenic T-Cell Lymphoma+7 more
University of Nebraska 54
Testing effectiveness (Phase 2)Looking for participantsNCT06463665
What this trial is testing

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Who this might be right for
Advanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non-Small Cell Lung CarcinomaMetastatic Non-squamous Non Small Cell Lung Cancer+5 more
Genelux Corporation 142
Large-scale testing (Phase 3)Ended earlyNCT04159155
What this trial is testing

Various Treatments in Serous or p53 Abnormal Endometrial Cancer

Who this might be right for
Endometrial CarcinomaP53 MutationSerous Carcinoma
University Health Network, Toronto 11
Large-scale testing (Phase 3)Study completedNCT00838357
What this trial is testing

A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).

Who this might be right for
Lymphoma (Non-Hodgkin's Lymphoma)Hodgkin's Disease or Multiple MyelomaFront Line Mobilization+1 more
Genzyme, a Sanofi Company 118
Large-scale testing (Phase 3)Ended earlyNCT01439347
What this trial is testing

Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)
Spectrum Pharmaceuticals, Inc 26
Not applicableUnknownNCT01761890
What this trial is testing

Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 147
Not applicableLooking for participantsNCT06248203
What this trial is testing

Teachers Leading the Front Lines - Adolescent

Who this might be right for
Adolescent BehaviorAdolescent - Emotional ProblemMental Health Issue+3 more
University of North Carolina, Chapel Hill 216
Large-scale testing (Phase 3)WithdrawnNCT00090675
What this trial is testing

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Testing effectiveness (Phase 2)Study completedNCT04294641
What this trial is testing

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Who this might be right for
Chronic GVHD
National Cancer Institute (NCI) 10
Early research (Phase 1)Active Not RecruitingNCT03549442
What this trial is testing

Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 40
Testing effectiveness (Phase 2)UnknownNCT01990144
What this trial is testing

Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With DLBCL: a Phase II Multicenter Study of the FIL

Who this might be right for
Diffuse Large B-cell Lymphoma
Fondazione Italiana Linfomi - ETS 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT06040320
What this trial is testing

Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

Who this might be right for
Post-transplant Lymphoproliferative Disorder
Washington University School of Medicine 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05627115
What this trial is testing

Response Adapted Incorporation of Tislelizumab Into the Front-line Treatment of Older Patients With Hodgkin lYmphoma

Who this might be right for
Hodgkin Lymphoma
University College, London 80
Early research (Phase 1)UnknownNCT04309084
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaNeoplasm, Plasma CellNeoplasms by Histologic Type+17 more
Celularity Incorporated 29
Testing effectiveness (Phase 2)Study completedNCT01089088
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 63
Testing effectiveness (Phase 2)UnknownNCT05963347
What this trial is testing

Go-CHOP as the Frontline Therapy for PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Henan Cancer Hospital 45
Next Page